Webinar: Best Practice and Solutions in the New Inflammation Paradigm

Presented by

Michael George, MD,

Vice President & Global Therapeutic Area Head - Inflammation

Dr. Michael George is the global therapeutic area head for Inflammation, Infectious Diseases, and General Medicine, based at the Covance office in Maidenhead, United Kingdom.

Dr. George obtained his degrees from London University and completed his medical training at Westminster and Charing Cross Medical School before undertaking his postgraduate training in Internal Medicine and gaining membership of the Royal College of Physicians in the UK.

Dr. George started his pharmaceutical career with Merck working in Medical Affairs and Clinical Development in cardiovascular and metabolic areas before moving to a global clinical development role at GSK. Later, Dr. George worked at Takeda Europe where he was responsible for successful registration of several innovative products during his time as Development Director and then later managing director of the European Development operation. He was responsible for spearheading the set-up of a Takeda’s regional development hub in Singapore in the rapidly growing Asia-Pacific region.

He has more than 21 years of experience in the pharmaceutical industry having held numerous posts of increasing seniority across all phases of clinical drug development in various therapeutic areas with both regional and global responsibility. His publications include numerous articles in the areas of hypertension, heart failure, diabetic retinopathy, and neuro-endocrine modulation.

Joan Meyer, PhD,

Executive Director, Operational Strategy & Planning - Inflammation

Dr. Joan Meyer is the Operational Strategy & Planning global therapeutic area head for Inflammation, Infectious Diseases, and General Medicine, reporting in to the Covance office in Princeton, NJ.

Dr. Meyer graduated from St. Mary’s University, Minnesota, with a BA in Biology and BA in Psychology. She received her Master of Science and PhD in Neuroscience from the University of Illinois at Urbana-Champaign, where she taught in the College of Medicine.

Dr. Meyer first joined Procter & Gamble, where she began her career in the research labs in the Health and Beauty Care area, discovering new therapies in the areas of dermatology, asthma, gastrointestinal, and pain. Dr. Meyer started the arthritis therapeutic focus area in P&G Pharmaceuticals, and took two compounds into clinical development.

While in the Clinical Development Division, Dr. Meyer led the development of drugs in the areas of arthritis, osteoporosis, gastrointestinal, urology, sleep and women’s health. She was Head of R&D for Urology, GI and Women’s Health, managing research, clinical development, medical & scientific affairs, and licensing and acquisition. She also had responsibility for the Products Research Group for Pharmaceuticals, whose remit was to understand the needs of patients, physicians, and third party payers, to develop new products to meet those needs, and communicate the benefits of P&G’s marketed products.

Following P&G, Dr. Meyer joined Kendle International. She held leadership positions in Project Management, Strategic Marketing, and served as Global Head for Study Start Up.

Dr. Meyer has more than 25 years of pharmaceutical and CRO experience and has served in leadership roles in the Ohio River Valley and National Arthritis Foundations. Her publications and presentations include the role of the brain in hypertension, arthritis, pain, and women’s health.